Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 51, Issue 6, Pages 813-818
Publisher
Springer Nature
Online
2016-02-15
DOI
10.1038/bmt.2016.7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study
- (2015) Yu Wang et al. BLOOD
- Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia
- (2015) A Ruggeri et al. LEUKEMIA
- Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts
- (2014) Anna Maria Raiola et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification
- (2014) Usanarat Anurathapan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS
- (2014) C. G. Kanakry et al. BLOOD
- Experts’ considerations on HLA-haploidentical stem cell transplantation
- (2014) Francesca Patriarca et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
- (2014) E. Angelucci et al. HAEMATOLOGICA
- Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
- (2014) Christopher G. Kanakry et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma
- (2013) Jennifer A. Kanakry et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Pretransplant Immunosuppression followed by Reduced-Toxicity Conditioning and Stem Cell Transplantation in High-Risk Thalassemia: A Safe Approach to Disease Control
- (2013) Usanarat Anurathapan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program
- (2013) Rosarin Sruamsiri et al. BMC HEALTH SERVICES RESEARCH
- Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts
- (2013) Vikram Mathews et al. PLoS One
- Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan
- (2012) M. E. Bernardo et al. BLOOD
- HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
- (2012) J. Bolanos-Meade et al. BLOOD
- Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
- (2012) Leo Luznik et al. SEMINARS IN ONCOLOGY
- Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation
- (2011) C. Cutler et al. BLOOD
- Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT
- (2011) S Yoshihara et al. BONE MARROW TRANSPLANTATION
- Immunohematologic Reconstitution in Pediatric Patients after T Cell-Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia
- (2010) Antonella Isgrò et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Novel pharmacokinetic behavior of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation: a prospective evaluation of pharmacokinetic and pharmacodynamic profile with therapeutic drug monitoring
- (2010) J. Gaziev et al. BLOOD
- HLA-matched sibling bone marrow transplantation for -thalassemia major
- (2010) M. Sabloff et al. BLOOD
- A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand
- (2010) Pattara Leelahavarong et al. BMC HEALTH SERVICES RESEARCH
- Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy
- (2009) Robert Chiesa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More